Lessons for investors from the 1800s
New data suggests that factors such as value, momentum and low beta have a long history of success
The hunt for ways to beat the market means that the investment industry has an enormous appetite for data on how different types of stocks have performed over time. The problem is that the data we have is more limited than you might expect. It’s quite decent for US stocks back to the 1920s, for example, because in the aftermath of the crash of 1929 and the Great Depression, American researchers began collating more financial and economic information. There are also long-term stock prices for many other countries, but there’s a shortage of long-term fundamental data.
This is an issue when you want to know whether a pattern of returns you have found only holds true for the limited amount of data you are working with (known as “in sample” in statistics), or whether it tends to occur across different markets and across time (“out of sample”). Findings that are only tested in sample will often be misleading – they may lead you to make wrong forecasts if you try to apply them more widely. Results that can be robustly replicated out of sample and in very different environments can be trusted much more as the basis for an investment strategy.
Reconstructing the past
So anybody interested in market history will be pleased by a new study from researchers at Dutch asset manager Robeco and Erasmus University at Rotterdam, who have put together data on US stocks from 1866 (when the country was just emerging from civil war) to 1926. This involved a great deal of work scanning old newspapers and other records to build up a database of 1,488 individual stocks (which explains why this kind of historical work is rare). The information available is limited – there are no earnings – but includes prices, market capitalisation and dividends.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
This allowed the researchers to test whether factors (see below) such as yield, size and momentum worked in this very old, very different out-of-sample data in the same way that they have in more recent history. Their results suggest that yield and momentum effects were present, as was low beta (the tendency of less volatile stocks to outperform more volatile ones). The size effect (smaller stocks beating larger ones) was not significant (one could speculate that some issues driving small-stocks today, such as less public research and information, were true more broadly back then).
There is one huge caveat to historical studies like this. It is possible that any apparent anomalies could not have been profitably exploited given higher trading costs or lower liquidity. That aside, this data seems to strengthen the idea that many factor effects are long-term consequences of human behaviour in markets rather than misleading patterns that appear solely by chance.
I wish I knew what factor investing was, but I’m too embarrassed to ask
A factor is a characteristic that has been shown to contribute to a stock, bond or other security outperforming the market. Research into factors was originally driven by academics trying to figure out why certain stocks tended to generate higher returns than theories about efficient markets would have predicted. Widely accepted factors include size (the observation that small companies tend to beat large firms over time); value (cheap companies beat expensive ones); yield (high-yielding stocks do better than low-yielding ones); and momentum (stocks that go up just keep on going up). These factors will not always beat the market over any given time period, but they have generated superior returns in many different global markets over the long run.
Factor investing has become increasingly popular in recent years, as the investment industry tries to exploit both the rapid growth in computing power that makes it easy to construct indices based on different factors and the growing disillusionment with active fund managers. Factor-based strategies are often described as “smart beta” – a label that implies they fall between traditional index funds (which aim to deliver the market return, or “beta”) and active funds (which aim to deliver above-market returns, or “alpha”). Today, investors can easily buy a momentum ETF that constantly rebalances into stocks with strong momentum or a value ETF that holds stocks viewed as cheap on certain metrics.
The problem with the race to find new factors for smart-beta funds to exploit is the risk of data mining. If you look at enough historical data, you can always find patterns that turn out to be simply statistical flukes. However, the established factors (such as those listed earlier) are widely accepted as valid – although whenever they endure a long period of underperformance, there will be questions about whether they still work.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
Rightmove: Asking prices edge closer to record peak
Asking prices have been driven up by the top-end of the market, Rightmove has found. But how does the situation look in your area?
By Vaishali Varu Published
-
Coventry Building Society bids £780m for Co-operative Bank - what could it mean for customers?
Coventry Building Society has put in an offer of £780 million to buy Co-operative Bank. When will the potential deal happen and what could it mean for customers?
By Vaishali Varu Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published
-
The end of China’s boom
Like the US, China too got fat on fake money. Now, China's doom is not far away.
By Bill Bonner Published
-
Magic mushrooms — an investment boom or doom?
Investing in these promising medical developments might see you embark on the trip of a lifetime.
By Bruce Packard Published